Rein Therapeutics (RNTX) Return on Capital Employed [ROCE] (2017 - 2026)
Rein Therapeutics' Return on Capital Employed [ROCE] was -135.79% in Q2 2026, down 12.75 percentage points from -123.04% a year earlier but up 297.94 percentage points from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Rein Therapeutics came in at -136.86%, down 53.76 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of -19.39 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -83.10% in FY2024 (-55.81 pp), -27.30% in FY2023 (+59.48 pp), -86.78% in FY2022 (+8.57 pp) and -95.35% in FY2021 (+22.13 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -433.73% (Q1 2026) and -18.83% (Q1 2024) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for seven straight quarters, with an average year-over-year change of -81.97 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2024 (a gain of 126.32 percentage points); the worst was Q1 2026 (a drop of 315.96 percentage points).
- Per Business Quant data, RNTX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -433.73% (Q1 2026), -154.59% (Q4 2025) and -121.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - | -135.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -135.79% |
| Mar 31, 2026 | -433.73% |
| Dec 31, 2025 | -154.59% |
| Sep 30, 2025 | -121.91% |
| Jun 30, 2025 | -123.04% |
| Mar 31, 2025 | -117.77% |
| Dec 31, 2024 | -84.06% |
| Sep 30, 2024 | -29.27% |
| Jun 30, 2024 | -25.68% |
| Mar 31, 2024 | -18.83% |
| Dec 31, 2023 | -29.58% |
| Sep 30, 2023 | -116.18% |
| Jun 30, 2023 | -126.51% |
| Mar 31, 2023 | -145.15% |
| Dec 31, 2022 | -130.19% |
| Sep 30, 2022 | -114.62% |
| Jun 30, 2022 | -94.37% |
| Mar 31, 2022 | -69.71% |
| Dec 31, 2021 | -56.47% |
| Sep 30, 2021 | -45.17% |
API Access
Rein Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();